Join the next BioMedical SIG webinar to discover The Venture Builder Model: Turning IP into Impact.
Turning groundbreaking biotech research into real-world solutions is often hindered by the infamous “valley of death” — the critical gap where funding is scarce, risk is high, and startups often fail to take shape. We will explore how the venture builder model can play a transformative role in bridging that gap and accelerating the path from lab bench to market.
In this session, we will discover:
- Why the valley of death is especially deep in biotech — and what it takes to cross it
- How venture builders provide the structure, resources, and expertise needed to de-risk academic IP
- Case studies of successful biotech startups launched from university research
- Practical strategies for TTOs to partner with venture builders and boost commercialization outcomes
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
